Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €457k.
Filing timeline
BuySaleNatalie Anne Marie Furney
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Natalie Anne Marie Furney: trading record in brief
Natalie Anne Marie Furney discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). Over a trading history stretching from 1 July 2026 to 10 August 2026, the count stands at 2 filings.
Every open-market trade on record is a sale: 1 sale worth €457k. Other entries cover 1 share grant.
On 12 August 2026 came the latest disclosure, an open-market sale for €457k in Takeda Pharmaceutical Co Ltd. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Natalie Anne Marie Furney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
30,868 shares@ US$17.100.0009% mcap100.0% of flowAmerican Depositary SharesSEC:0001493152-26-037480:0
43,886 shares0American Depositary SharesSEC:0001395064-26-000253:0
2 of 2 declarations
